Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21620-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#21620-1-AP, RRID:AB_10858623
- Product name
- TMED9 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TMED9 antibody (Cat. #21620-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat, pig and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ACBD3 modulates KDEL receptor interaction with PKA for its trafficking via tubulovesicular carrier.
A new type of ERGIC-ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis.
High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma.
A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion.
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Yue X, Qian Y, Zhu L, Gim B, Bao M, Jia J, Jing S, Wang Y, Tan C, Bottanelli F, Ziltener P, Choi S, Hao P, Lee I
BMC biology 2021 Sep 7;19(1):194
BMC biology 2021 Sep 7;19(1):194
A new type of ERGIC-ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis.
Li S, Yan R, Xu J, Zhao S, Ma X, Sun Q, Zhang M, Li Y, Liu JG, Chen L, Li S, Xu K, Ge L
Cell research 2021 Sep 24;
Cell research 2021 Sep 24;
High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma.
Ju G, Xu C, Zeng K, Zhou T, Zang L
Bioengineered 2021 Dec;12(1):8965-8979
Bioengineered 2021 Dec;12(1):8965-8979
A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion.
Zhang M, Liu L, Lin X, Wang Y, Li Y, Guo Q, Li S, Sun Y, Tao X, Zhang D, Lv X, Zheng L, Ge L
Cell 2020 Apr 30;181(3):637-652.e15
Cell 2020 Apr 30;181(3):637-652.e15
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy.
Dvela-Levitt M, Kost-Alimova M, Emani M, Kohnert E, Thompson R, Sidhom EH, Rivadeneira A, Sahakian N, Roignot J, Papagregoriou G, Montesinos MS, Clark AR, McKinney D, Gutierrez J, Roth M, Ronco L, Elonga E, Carter TA, Gnirke A, Melanson M, Hartland K, Wieder N, Hsu JC, Deltas C, Hughey R, Bleyer AJ, Kmoch S, Živná M, Barešova V, Kota S, Schlondorff J, Heiman M, Alper SL, Wagner F, Weins A, Golub TR, Lander ES, Greka A
Cell 2019 Jul 25;178(3):521-535.e23
Cell 2019 Jul 25;178(3):521-535.e23
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse liver tissue were subjected to SDS PAGE followed by western blot with 21620-1-AP(TMED9 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using TMED9 antibody 21620-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver using 21620-1-AP(TMED9 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human liver using 21620-1-AP(TMED9 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue